Products
Platform
Research
Market
Learn
Compare SBI Healthcare Opportunities Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.93 | 1.87 |
NAV | ₹435.81 | ₹40.60 |
Fund Started | 04 Jun 1999 | 25 Jun 2018 |
Fund Size | ₹3963.38 Cr | ₹6161.81 Cr |
Exit Load | Exit load of 0.50% if redeemed within 15 days | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹500
₹100
Expense Ratio
1.93
1.87
NAV
₹435.81
₹40.60
Fund Started
04 Jun 1999
25 Jun 2018
Fund Size
₹3963.38 Cr
₹6161.81 Cr
Exit Load
Exit load of 0.50% if redeemed within 15 days
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 4.41% | 3.41% |
3 Year | 26.19% | 28.37% |
5 Year | 20.78% | 21.82% |
1 Year
4.41%
3.41%
3 Year
26.19%
28.37%
5 Year
20.78%
21.82%
Holding Analysis
Equity | 96.19% | 95.88% |
Cash | 3.74% | 4.12% |
Equity
96.19%
95.88%
Cash
3.74%
4.12%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.86% |
Divi's Laboratories Ltd. | 6.81% |
Max Healthcare Institute Ltd. | 6.12% |
Cipla Ltd. | 4.81% |
Lonza Group Ag | 4.24% |
Lupin Ltd. | 4.02% |
Torrent Pharmaceuticals Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.49% |
Fortis Healthcare Ltd. | 3.45% |
Gland Pharma Ltd. | 3.31% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.71% |
Dr. Reddy's Laboratories Ltd. | 9.47% |
Divi's Laboratories Ltd. | 9.23% |
Cipla Ltd. | 7.39% |
Aurobindo Pharma Ltd. | 6.53% |
Lupin Ltd. | 5.44% |
Alkem Laboratories Ltd. | 4.00% |
Mankind Pharma Ltd. | 3.50% |
Biocon Ltd. | 3.21% |
Gland Pharma Ltd. | 2.88% |
Fund Manager
Name | Tanmaya Desai | Dharmesh Kakkad |
Start Date | 27 Jun 2011 | 23 Feb 2021 |
Name
Tanmaya Desai
Dharmesh Kakkad
Start Date
27 Jun 2011
23 Feb 2021
About Fund
Description | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 04 Jun 1999 | 25 Jun 2018 |
Description
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Jun 1999
25 Jun 2018
